Pursuant to SEBI(Prohibition of Insider Trading) Regulations, 2015 we wish to inform you that, the Trading window for dealing in the securities of the Comapny will remain closed w.e.f 1st July, 2025 for quarter ended June 30, 2025.

pdf

Auro Laboratories Ltd.

11 Jun 2025

282.80

7.08%

SAST

Auro Laboratories Ltd - 530233 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Saloni Siddhartha Deorah

pdf

Auro Laboratories Ltd.

02 Jun 2025

282.80

7.08%

Company Update

Auro Laboratories Ltd - 530233 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Auro Laboratories Limited has submitted the clippings of newspaper publications of the Financial Results for the quarter and year ended March 31, 2025.

pdf

Auro Laboratories Ltd.

31 May 2025

282.80

7.08%

Company Update

Auro Laboratories Ltd - 530233 - Disclosure Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure …

BSE India

Disclosure under Regulation 30(5) of SEBI (LODR) Regulations, 2015.

pdf

Auro Laboratories Ltd.

30 May 2025

282.80

7.08%

Board Meeting

Auro Laboratories Ltd - 530233 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

Auro Laboratories Limited has submitted the Outcome of the Board Meeting held on May 30, 2025.

pdf

Auro Laboratories Ltd.

21 May 2025

282.80

7.08%

Company Update

Auro Laboratories Ltd - 530233 - Update on board meeting

BSE India

The Board Meeting to be held on 23/05/2025 has been revised to 30/05/2025 The Board Meeting to be held on 23/05/2025 has been revised to 30/05/2025 due to certain exigencies.

pdf

Auro Laboratories Ltd.

15 May 2025

282.80

7.08%

Board Meeting

Auro Laboratories Ltd - 530233 - Board Meeting Intimation for Audited Financial Results For The Quarter …

BSE India

Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve financial results for the quarter and year ended March 31, 2025 and any other matter with the permission of chair.

pdf

Auro Laboratories Ltd.

18 Apr 2025

282.80

7.08%

Company Update

Auro Laboratories Ltd - 530233 - Execution Of Agreement Of Hypothecation Of Movables

BSE India

Pursuant to Regulation 30 read with Part B of Part A of Schedule III of SEBI (LODR) Regulation, 2015, we wish to inform you that the Auro Laboratories Limited ("the Company") has entered into Agreement of Hypothecation of Movables ("the Agreement") with Indian Bank Limited ("the Bank").

pdf

Is Auro Laboratories Ltd. worth buying?

52 Votes:

Buy 75.0%

Sell 13.46%

Hold 11.54%

80.82% Gain from 52W Low

High volume+gain today

Auro Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Auro Laboratories Ltd. on BSE